Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease

被引：263

作者：

Ayton, Scott ^{[1
]}

Lei, Peng ^{[1
]}

Duce, James A. ^{[1
]}

Wong, Bruce X. W. ^{[1
]}

Sedjahtera, Amelia ^{[1
]}

Adlard, Paul A. ^{[2
,3
]}

Bush, Ashley I. ^{[1
,3
]}

Finkelstein, David I. ^{[1
,2
]}

机构：

[1] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Oxidat Biol Lab, Parkville, Vic, Australia

[2] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia

[3] Univ Melbourne, Dept Pathol, Parkville, Vic, Australia

来源：

ANNALS OF NEUROLOGY | 2013年 / 73卷 / 04期

基金：

英国医学研究理事会; 澳大利亚研究理事会;

关键词：

NIGRAL IRON DEPOSITION; FERROXIDASE ACTIVITY; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; SUBSTANTIA-NIGRA; SERUM; GENE; NEURONS; COPPER; EXPORT;

D O I：

10.1002/ana.23817

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

100204 [神经病学];

摘要：

Ceruloplasmin is an iron-export ferroxidase that is abundant in plasma and also expressed in glia. We found a approximate to 80% loss of ceruloplasmin ferroxidase activity in the substantia nigra of idiopathic Parkinson disease (PD) cases, which could contribute to the pro-oxidant iron accumulation that characterizes the pathology. Consistent with a role for ceruloplasmin in PD etiopathogenesis, ceruloplasmin knockout mice developed parkinsonism that was rescued by iron chelation. Additionally, peripheral infusion of ceruloplasmin attenuated neurodegeneration and nigral iron elevation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model for PD. These findings show, in principle, that intravenous ceruloplasmin may have therapeutic potential in PD. Ann Neurol 2013;73:554-559

引用

收藏

页码：554 / 559

页数：6

相关论文

共 24 条

[1]

Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease [J].

Bharucha, Kersi J. ;

Friedman, Joyce K. ;

Vincent, Andrea S. ;

Ross, Elliott D. .

JOURNAL OF NEUROLOGY, 2008, 255 (12) :1957-1962

[2]

Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NOx content in the CSF.: A different marker profile in four neurodegenerative diseases [J].

Boll, Marie-Catherine ;

Alcaraz-Zubeldia, Mireya ;

Montes, Sergio ;

Rios, Camilo .

NEUROCHEMICAL RESEARCH, 2008, 33 (09) :1717-1723

[3]

Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease [J].

Boll, MC ;

Sotelo, J ;

Otero, E ;

Alcaraz-Zubeldia, M ;

Rios, C .

NEUROSCIENCE LETTERS, 1999, 265 (03) :155-158

[4]

Sequestration of iron by Lewy bodies in Parkinson's disease [J].

Castellani, RJ ;

Siedlak, SL ;

Perry, G ;

Smith, MA .

ACTA NEUROPATHOLOGICA, 2000, 100 (02) :111-114

[5]

BASAL LIPID-PEROXIDATION IN SUBSTANTIA NIGRA IS INCREASED IN PARKINSONS-DISEASE [J].

DEXTER, DT ;

CARTER, CJ ;

WELLS, FR ;

JAVOYAGID, F ;

AGID, Y ;

LEES, A ;

JENNER, P ;

MARSDEN, CD .

JOURNAL OF NEUROCHEMISTRY, 1989, 52 (02) :381-389

[6]

Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease [J].

Duce, James A. ;

Tsatsanis, Andrew ;

Cater, Michael A. ;

James, Simon A. ;

Robb, Elysia ;

Wikhe, Krutika ;

Leong, Su Ling ;

Perez, Keyla ;

Johanssen, Timothy ;

Greenough, Mark A. ;

Cho, Hyun-Hee ;

Galatis, Denise ;

Moir, Robert D. ;

Masters, Colin L. ;

McLean, Catriona ;

Tanzi, Rudolph E. ;

Cappai, Roberto ;

Barnham, Kevin J. ;

Ciccotosto, Giuseppe D. ;

Rogers, Jack T. ;

Bush, Ashley I. .

CELL, 2010, 142 (06) :857-867

[7]

Ceruloplasmin metabolism and function [J].

Hellman, NE ;

Gitlin, JD .

ANNUAL REVIEW OF NUTRITION, 2002, 22 :439-458

[8]

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease [J].

Hochstrasser, H ;

Bauer, P ;

Walter, U ;

Behnke, S ;

Spiegel, J ;

Csoti, I ;

Zeiler, B ;

Bornemann, A ;

Pahnke, J ;

Becker, G ;

Riess, O ;

Berg, D .

NEUROLOGY, 2004, 63 (10) :1912-1917

[9]

Nigral iron deposition occurs across motor phenotypes of Parkinson's disease [J].

Jin, L. ;

Wang, J. ;

Jin, H. ;

Fei, G. ;

Zhang, Y. ;

Chen, W. ;

Zhao, L. ;

Zhao, N. ;

Sun, X. ;

Zeng, M. ;

Zhong, C. .

EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (07) :969-976

[10]

Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease [J].

Jin, Lirong ;

Wang, Jian ;

Zhao, Lei ;

Jin, Hang ;

Fei, Guoqiang ;

Zhang, Yuwen ;

Zeng, Mengsu ;

Zhong, Chunjiu .

BRAIN, 2011, 134 :50-58